SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001104659-18-023060
Filing Date
2018-04-09
Accepted
2018-04-09 16:15:18
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 17257
2 GRAPHIC g93822bgi001.gif GRAPHIC 1900
3 GRAPHIC g93822bgi002.gif GRAPHIC 9881
  Complete submission text file 0001104659-18-023060.txt   34763
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations